Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-30 Sale | 2024-11-01 8:59 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 20,000 | $32.6 | $651,960 | 173,205 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 8:57 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 91,634 | $31.41 | $2,878,038 | 1,016,725 (Direct) | View |
| 2024-10-14 Sale | 2024-10-16 8:06 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 40,000 | $30.15 | $1,206,080 | 327,002 (Indirect Direct) | View |
| 2024-10-14 Sale | 2024-10-16 8:06 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 20,961 | $30.37 | $636,490 | 114,897 (Direct) | View |
| 2024-10-01 Sale | 2024-10-03 8:09 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 10,000 | $28.18 | $281,770 | 286,286 (Indirect Direct) | View |
| 2024-09-20 Sale | 2024-09-23 6:00 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,500 | $27.65 | $152,086 | 103,253 (Direct) | View |
| 2024-09-16 Sale | 2024-09-18 9:19 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 8,393 | $27.54 | $231,175 | 185,450 (Direct) | View |
| 2024-09-10 Sale | 2024-09-13 5:16 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 568 | $26.18 | $14,870 | 296,286 (Indirect Direct) | View |
| 2024-09-10 Sale | 2024-09-13 5:14 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 637 | $26.18 | $16,677 | 75,294 (Direct) | View |
| 2024-09-10 Sale | 2024-09-13 5:13 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 639 | $26.18 | $16,729 | 41,152 (Direct) | View |
| 2024-09-10 Sale | 2024-09-13 5:11 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 537 | $26.18 | $14,059 | 180,705 (Direct) | View |
| 2024-09-10 Sale | 2024-09-13 5:10 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,738 | $26.18 | $45,501 | 605,417 (Direct) | View |
| 2024-09-03 Sale | 2024-09-05 4:08 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $26.72 | $133,588 | 296,854 (Indirect Direct) | View |
| 2024-09-03 Sale | 2024-09-05 4:05 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 949 | $27.61 | $26,206 | 94,646 (Direct) | View |
| 2024-08-26 Sale | 2024-08-29 4:30 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 98,334 | $27.02 | $2,657,250 | 231,289 (Direct) | View |
| 2024-08-23 Sale | 2024-08-28 11:11 am | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 14,051 | $27.52 | $386,714 | 120,459 (Direct) | View |
| 2024-08-01 Sale | 2024-08-02 9:32 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $26.75 | $133,756 | 301,854 (Indirect Direct) | View |
| 2024-07-23 Sale | 2024-07-25 5:54 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 161,855 | $27.07 | $4,381,867 | 323,431 (Direct) | View |
| 2024-07-16 Sale | 2024-07-18 9:41 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 34,811 | $28.04 | $976,274 | 236,317 (Direct) | View |
| 2024-07-01 Sale | 2024-07-02 6:55 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $23.4 | $117,020 | 306,854 (Indirect Direct) | View |
| 2024-06-11 Sale | 2024-06-13 6:13 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 2,516 | $22.64 | $56,965 | 310,790 (Indirect Direct) | View |
| 2024-06-11 Sale | 2024-06-13 6:11 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 2,825 | $22.64 | $63,961 | 74,867 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 6:09 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 2,831 | $22.64 | $64,094 | 46,799 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 6:06 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 2,380 | $22.64 | $53,886 | 180,178 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 6:04 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 569 | $22.64 | $12,883 | 18,562 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 6:01 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 7,894 | $22.64 | $178,728 | 581,553 (Direct) | View |
| 2024-06-03 Sale | 2024-06-05 5:05 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $19.29 | $96,440 | 313,306 (Indirect Direct) | View |
| 2024-05-01 Sale | 2024-05-02 9:07 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $20.15 | $100,750 | 318,306 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-30 Exercise | 2024-11-01 8:59 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 20,000 | $21.1 | 173,205 (Direct) | View |
| 2024-10-30 Exercise | 2024-11-01 8:59 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 20,000 | $0 | 173,205 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-18 8:57 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 91,634 | $21.1 | 1,016,725 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-18 8:57 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 91,634 | $0 | 1,016,725 (Direct) | View |
| 2024-10-14 Exercise | 2024-10-16 8:06 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 40,000 | $21.09 | 327,002 (Direct) | View |
| 2024-10-14 Exercise | 2024-10-16 8:06 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 40,000 | $0 | 327,002 (Direct) | View |
| 2024-10-15 Exercise | 2024-10-16 8:06 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 19,825 | $0.615 | 114,897 (Direct) | View |
| 2024-10-15 Exercise | 2024-10-16 8:06 pm | N/A 2028-09-26 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 19,825 | $0 | 114,897 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-23 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,500 | $0.615 | 103,253 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-23 6:00 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,500 | $0 | 103,253 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 9:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 8,393 | $0.615 | 185,450 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 9:19 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 8,393 | $0 | 185,450 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-05 4:05 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 949 | $0.615 | 94,646 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-05 4:05 pm | N/A 2028-09-26 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 949 | $0 | 94,646 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-29 4:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 24,372 | $19.87 | 231,289 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-29 4:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 32,671 | $7.009 | 231,289 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-29 4:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 41,291 | $21.09 | 231,289 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-29 4:30 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 98,334 | $0 | 231,289 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-28 11:11 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 14,051 | $0.615 | 120,459 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-28 11:11 am | N/A 2028-09-26 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 14,051 | $0 | 120,459 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 11:45 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 24,538 | $0.615 | 607,155 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 11:45 am | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 24,538 | $0 | 607,155 (Direct) | View |
| 2024-07-23 Exercise | 2024-07-25 5:54 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 161,855 | $7.009 | 323,431 (Direct) | View |
| 2024-07-23 Exercise | 2024-07-25 5:54 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 161,855 | $0 | 323,431 (Direct) | View |
| 2024-07-16 Exercise | 2024-07-18 9:41 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 29,803 | $7.009 | 236,317 (Direct) | View |
| 2024-07-16 Exercise | 2024-07-18 9:41 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 29,803 | $0 | 236,317 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:57 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,064 | $19.94 | 181,242 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:56 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 1,064 | $19.94 | 75,931 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:56 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 221 | $19.94 | 18,783 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:55 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,064 | $19.94 | 582,617 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:55 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 1,064 | $19.94 | 306,854 (Direct) | View |
| 2024-06-08 Option Award | 2024-06-11 5:31 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Xu Yuan Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-08 Option Award | 2024-06-11 5:29 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-08 Option Award | 2024-06-11 5:28 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-08 Option Award | 2024-06-11 5:25 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-08 Option Award | 2024-06-11 5:24 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-08 Option Award | 2024-06-11 5:22 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-08 Option Award | 2024-06-11 5:20 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Judy Chou Director | 26,000 | $0 | 26,000 (Direct) | View |